3-(3-hydroxyphenyl)-3-hydroxypropanoic acid has been researched along with Clostridium Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shaw, W | 1 |
1 other study(ies) available for 3-(3-hydroxyphenyl)-3-hydroxypropanoic acid and Clostridium Infections
| Article | Year |
|---|---|
Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Autistic Disorder; Child; Child, Preschool; Clostridioides difficile; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Gastrointestinal Tract; Humans; Male; Middle Aged; Phenylalanine; Phenylpropionates; Schizophrenia; Sex Characteristics; Vancomycin; Young Adult | 2010 |